Endocrinology

Back to articles

New recommendations on use of hormone therapy for primary prevention of chronic conditions in postmenopausal women

KEY POINT

The United States Preventive Services Task Force (USPSTF) released an updated statement on the use of hormone therapy for the primary prevention of chronic conditions in postmenopausal women. The statement recommends against the combined use of estrogen and progesterone in those with an intact uterus and against the use of estrogen alone for those who have had a hysterectomy.

SOURCES

US Preventive Services Task Force Recommendation Statement. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women. JAMA. 2017;318(22):2224–33.

Lewis CE, et al. Menopausal hormone therapy for primary prevention of chronic disease. JAMA. 2017;318(22):2187–9.

Grady D. Evidence for postmenopausal hormone therapy to prevent chronic conditions: Success, failure, and lessons learned. JAMA Intern Med. 2017;[Epub ahead of print].

Wenger NK. Menopausal hormone therapy for the primary prevention of chronic conditions: Unfulfilled expectations. JAMA Cardiol. 2017;[Epub ahead of print].